Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance

Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance


Hong Kong is reducing the amount of time travelers will need to serve hotel quarantine, from seven days down to three starting Friday.

“The seven-day quarantine hotel arrangement will be changed to three days in a quarantine hotel, plus four days of home medical surveillance,” Chief Executive John Lee said at a press conference Monday.

After completing the hotel quarantine, travelers can stay at home or in a hotel for the four days of surveillance. During this period people will be able to leave their place of residence, but cannot enter “places where there is active checking of vaccine passes,” Lee said in Cantonese.

That includes bars, pubs, gyms and beauty parlors. People are also not allowed to visit nursing homes, schools and specified medical premises during the surveillance period.

“They cannot participate in any activities where masks are to be taken off,” Lee added. If they test negative on a rapid antigen test, they can take public transportation, go to work and enter shopping malls, he said.

“We have to strike a balance between risk level as well as our economic activity. Where risks could be controlled, we want to preserve maximum movement of people and to maintain Hong Kong’s competitiveness,” Lee said.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Health

Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug

Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise.  The company last week said it would buy […]

Read More
Trump, Pfizer to announce agreement to lower Medicaid drug prices
Health

Trump, Pfizer to announce agreement to lower Medicaid drug prices

U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices […]

Read More